Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Cue Health Inc. (HLTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Sales Agreement, by and between Cue Health Inc. and Cowen and Company, LLC",
"Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation"
08/09/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Cue Health Reports Second Quarter 2023 Financial Results"
08/07/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/03/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes"
07/31/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
06/28/2023 4 Khattak Ayub K (President and CEO) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 21,097 shares @ $0.438, valued at $9.2k
06/28/2023 4 Sever Clint (Chief Product Officer) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 25,782 shares @ $0.438, valued at $11.3k
06/09/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/07/2023 4 Sever Clint (Chief Product Officer) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 15,885 shares @ $0.6, valued at $9.5k
06/07/2023 4 Pollard Randall E. (Chief Accounting Officer) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 14,851 shares @ $0.6, valued at $8.9k
06/07/2023 4 Khattak Ayub K (President and CEO) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 9,064 shares @ $0.6, valued at $5.4k
06/07/2023 4 Palsis Erica (General Counsel) has filed a Form 4 on Cue Health Inc.
Txns: Granted 80,000 shares @ $0
Paid exercise price by delivering 6,272 shares @ $0.6, valued at $3.8k
06/07/2023 4 Achar Christopher K (Director) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 6,965 shares @ $0.6, valued at $4.2k
06/07/2023 4 Bradford K Joanne (Director) has filed a Form 4 on Cue Health Inc.
Txns: Granted 63,300 shares @ $0
06/07/2023 4 Martinez Maria (Director) has filed a Form 4 on Cue Health Inc.
Txns: Granted 63,300 shares @ $0
06/07/2023 4 Faig Carole T (Director) has filed a Form 4 on Cue Health Inc.
Txns: Granted 63,300 shares @ $0
06/07/2023 4 Ghaim Joshua (Director) has filed a Form 4 on Cue Health Inc.
Txns: Granted 63,300 shares @ $0
06/07/2023 4 Javed Aasim (CFO) has filed a Form 4 on Cue Health Inc.
Txns: Paid exercise price by delivering 11,626 shares @ $0.6, valued at $7k
06/07/2023 4 Jain Sachin H. (Director) has filed a Form 4 on Cue Health Inc.
Txns: Granted 63,300 shares @ $0
06/07/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure  Interactive Data
06/06/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test Cue’s COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company’s innovative test-to-treatment platform"
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 ARS Form ARS - Annual Report to Security Holders:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/20/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test"
03/16/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy